News | September 01, 2008

Cardiac Imaging Studies Show Economic Value

September 2, 2008 – Two recent studies demonstrate the economical value of cardiac imaging, showing MDCT to be cost-effective for men and cost-saving for women, and demonstrating how echo is cost-effective in determining patient eligibility for ICDs (implantable cardioverter-defibrillators).

In a study recently published in the American Journal of Roentgenology, lead investigator Joseph Ladapo, M.D., and his team at Harvard, identified cost-benefits of cardiac imaging by evaluating patients who presented to the ER with low-risk chest pain. Their research compared the “standard of care” to multidetector CT (MDCT) coronary angiography-base management and found MDCT to be cost-effective for men, and cost-saving for women. Hospital costs decreased by an average of $410 per female, while general per capita health care expenditures fell $380 for women.

“Because coronary CT angiography is so good at ruling out disease, women…are much more likely to avoid a costly admission," said Dr. Ladapo. "I think there’s a strong case for reimbursing this technology when it’s used in women, but it’s cost-effective and ought to be reimbursed in men, too.”

In another study, led by Andrew Krahn, M.D., and published in this month’s Journal of the American College of Cardiology, researchers demonstrated the cost-effectiveness of repeated echocardiography and multigated acquisition (MUGA) scanning in determining patient eligibility for an implantable cardioverter-defibrillator (ICD). Using a prospective cohort study that looked at 100 patients referred for an ICD, the test results showed that using cardiac imaging to verify the heart's blood pumping capacity resulted in identifying a significant number of patients – 31 of the 100 included in the study – as ineligible for an ICD. These findings ultimately lead to $603,722 in total savings, or approximately $6,037 per patient.

“Access to high quality medical imaging has proven to be an essential factor in cardiac care, and it is crucial that patients, doctors and policymakers alike look to studies like these as yet another example of how imaging technology can improve patient treatment while reducing overall costs,” said Maureen Zilly, director, Government Relations, MITA. MITA is highlighting these studies to the industry not only to applaud the work of Dr. Krahn and Dr. Ladapo but to remind policy makers of the importance of medical imaging technology in treating heart disease and mitigating healthcare costs.

For more information: www.medicalimaging.org

Related Content

CT Offers Non-Invasive Alternative for Complex Coronary Disease Treatment Planning based on data from the SYNTAX III Trial. The use of FFR-CT in the trial showed better planning for interventional procedures.

CT cffers a non-invasive alternative for complex coronary disease treatment planning based on data from the SYNTAX III Trial. 

News | CT Angiography (CTA) | October 16, 2018
A new study published in the European Heart Journal shows computed tomography (CT) can be a useful aid in heart team...
A comparison of CT image of heavily calcified coronary arteries that appear to present a significant hemodynamic blockages and the correspending FFR-CT showing the patient had adequate blood flow and does not need a diagnostic angiogram or intervention.

A comparison of a CT image of heavily calcified coronary arteries that appear to present a significant hemodynamic blockage and the corresponding FFR-CT showing the patient had adequate blood flow and does not need a diagnostic angiogram or intervention. Image courtesy of Kavitha Chinnaiyan, William Beaumont Hospital.

Feature | CT Angiography (CTA) | July 23, 2018 | Dave Fornell, Editor
The use of non-invasive fractional flow reserve CT (FFR-CT) was the hottest topic discussed at the Society of Cardiov
Videos | CT Angiography (CTA) | July 19, 2018
Kavitha Chinnaiyan, M.D., FACC, FSCCT, associate professor, Oakland University, William Beaumont School of Medicine,
Videos | CT Angiography (CTA) | July 18, 2018
A discussion with Gianluca Pontone, M.D., Ph.D., FSCCT, director of cardiovascular MRI, Centro Cardiologico Manzino,
Videos | CT Angiography (CTA) | July 17, 2018
A discussion with Todd Villines, M.D., FACC, FAHA, FSCCT, director of cardiovascular research and cardiac CT programs
HeartFlow Announces New Commercial Coverage With UnitedHealthcare
News | CT Angiography (CTA) | July 03, 2018
HeartFlow Inc. announced that UnitedHealthcare now covers the HeartFlow FFRct Analysis, extending access to their 45...
Post-Mortem CT Angiography Illuminates Causes of Death
News | CT Angiography (CTA) | June 25, 2018
Computed tomography (CT) angiography is a useful adjunct to autopsy that is likely to increase the quality of post-...
iSchemaView Receives FDA Clearance for Rapid CTA
Technology | CT Angiography (CTA) | May 01, 2018
Cerebrovascular imaging analysis company iSchemaView received final clearance from the U.S. Food and Drug...
The use of metal artifact reduction software on this CCTA (CTA) cardiac CT from an Canon, Toshiba, Aquilion Precision, allows clear visualization inside a coronary stent. The 0.25 mm high-resolution reconstruction also helps delineate the various components of plaque.

The use of metal artifact reduction software on this Aquilion Precision image allows clear visualization inside a coronary stent. The 0.25 mm high-resolution reconstruction also helps delineate the various components of plaque.

Feature | CT Angiography (CTA) | April 26, 2018 | Dave Fornell
There have been a few big, recent advancements in cardiac computed tomography angiography (CCTA) imaging technology.
Siemens Healthineers, Florida Hospital Collaborate to Improve Healthcare Outcomes
News | CT Angiography (CTA) | January 23, 2018
January 23, 2018 – Siemens Healthineers and Florida Hospital, part of Adventist Health System, have announced a multi
Overlay Init